In the article on Bortezomib's inhibition of nuclear factor-KB-dependent survival and its potent in vivo activity in mesothelioma, beginning on page 5942 of the October 1, 2007, issue of Clinical Cancer Research, the affiliations for two authors were incorrectly stated. Dr. Andrea Sartore-Bianchi and Dr. Camillo Porta are affiliated with the Institute of Internal Medicine and Medical Oncology, IRCCS Policlinico San Matteo University Hospital, 1-27100 Pavia, Italy. In addition, the current address of Andrea Sartore-Bianchi is as follows: Falck Division of Medical Oncology, Niguarda Ca' Granda Hospital, Milano, Italy.